Kimberly-Clark Corporation(KMB)

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.
Latest News & Analysis
Kimberly-Clark's Kenvue Gamble: A Strategic Pivot at an Inopportune Moment
[KMB](/dashboard/companies/KMB)'s $48.7B Kenvue deal shifts focus from stability to M&A risk, with regulatory and litigation risks clouding growth.
Kimberly-Clark's Transformation: Market Impact and Industry Trends in 2025
A detailed analysis of Kimberly-Clark’s transformation strategy, Q4 earnings, and dividend increase with actionable insights.
Kimberly-Clark Navigates Transformation: Q4 Earnings, Dividend Hike, and Market Impact
A comprehensive analysis of [KMB] reveals key Q4 2024 results, dividend updates, and strategies shaping long-term market impact.
Kimberly-Clark Corporation News Update (Failed Generation)
Content generation failed - Recovery needed
Kimberly-Clark Transformation: Q4 2024 Results & Future Outlook
An in-depth analysis of Kimberly-Clark's Q4 2024 performance, dividend increase, and strategic initiatives amid current market challenges.
Kimberly-Clark (KMB): Strategic Analysis, Challenges, and Future Outlook
Kimberly-Clark (KMB) balances stock gains with growth concerns. The 'Powering Care' strategy aims for innovation, but faces volatility. Dividend appeal requires financial health analysis.
Kimberly-Clark (KMB) Stock Analysis: Dividend, Growth, Challenges
Kimberly-Clark (KMB) faces a mixed outlook amid strategic shifts and market volatility. Dividend appeal clashes with growth concerns. A detailed analysis follows.
Kimberly-Clark (KMB): Navigating Market Dynamics and Strategic Priorities
Kimberly-Clark faces a mixed outlook with strengths in dividends and brand recognition offset by challenges in growth and margins. The 'Powering Care' strategy aims to address these issues.
Kimberly-Clark (KMB): Navigating Economic Headwinds and Industry Trends
Kimberly-Clark (KMB) navigates economic headwinds and industry trends amid mixed analyst sentiment, balancing dividend stability with strategic transformation. Investors should remain cautious.
Kimberly-Clark (KMB): Navigating a Shifting Consumer Market
Kimberly-Clark navigates shifting consumer preferences while maintaining its dividend king status. A look at KMB's strategy, risks, and opportunities.
Kimberly-Clark Corporation (KMB): Market Trends and Business Developments
Kimberly-Clark (KMB) navigates a dynamic market with its "Powering Care" strategy amid currency volatility and softening demand. Dividend increases signal financial stability.
Kimberly-Clark Corporation: Innovation, Dividends, and Financial Resilience
A detailed analysis of Kimberly-Clark’s robust net income growth, dividend strategy, and innovative technology driving market resilience.
Kimberly-Clark (KMB): Ethics, Innovation, and Economic Resilience
Kimberly-Clark (KMB) navigates 2025 with a focus on ethics and innovation amid economic challenges. Dividend aristocrat status offers stability in a volatile market.
Kimberly-Clark (KMB): Ethical Leadership, Innovation, and Dividends
Kimberly-Clark (KMB) navigates 2025 with ethical leadership, innovation, and dividend stability amid market volatility. Strategic adaptation is key to sustaining growth.
Kimberly-Clark (KMB): Growth Strategy, Innovation, and Market Resilience
Kimberly-Clark (KMB) navigates economic headwinds with innovation, ethical practices, and a strong dividend. Analysis of growth strategy, market resilience, and financial performance.
Kimberly-Clark (KMB): Ethics, Innovation, and Portfolio Strategy
Kimberly-Clark (KMB) balances ethical practices, innovation, and portfolio optimization in the Household & Personal Products sector, positioning it for sustainable growth.
Kimberly-Clark (KMB): Q1 2025 Earnings, Dividend Analysis
A comprehensive analysis of Kimberly-Clark's (KMB) Q1 2025 earnings preview, dividend sustainability, and strategic outlook, including the impact of WypAll and the 'Powering Care' strategy.
Kimberly-Clark (KMB) Financial Analysis: Q1 2025 Outlook & Strategic Review
Kimberly-Clark (KMB) anticipates a challenging Q1 2025, navigating soft demand, retail destocking, and rising costs despite recent margin gains and product innovation efforts.
Kimberly-Clark (KMB) Strategic Pivot: Financial Impact & Future Growth
Kimberly-Clark's strategic pivot: divesting Latin American tissue for $2.125B to fuel core North American growth and bolster margins via 'Powering Care' initiative.
Kimberly-Clark's Strategic Pivot: $3.4B Divestiture, Powering Care Efficiency & Dividend Resilience
Kimberly-Clark's $3.4B international tissue divestiture and Powering Care cost savings reshape margins and sustain its Dividend King status.
Kimberly-Clark's Strategic Shift: Analyzing the Suzano Deal
Kimberly-Clark is reshaping its portfolio through a major divestiture and joint venture, aiming to boost margins and focus on core, high-growth segments.
Kimberly-Clark Corporation Q2 2025 Update: Strategic Pivot, Suzano JV & Dividend Sustainability
Kimberly-Clark advances strategic realignment with Suzano JV, operational efficiencies, and robust dividend growth, shaping its competitive edge and financial outlook.
Kimberly-Clark Corporation Q2 2025 Earnings: Powering Care Strategy Drives Margin Expansion and Shareholder Value
Kimberly-Clark's Q2 2025 earnings highlight margin improvements, growth in Personal Care, and strategic gains from the Suzano JV, underpinning long-term value.
Kimberly-Clark Corporation Q2 2025 Earnings and Strategic Transformation Analysis
Explore Kimberly-Clark's Q2 2025 earnings surge, Powering Care strategy, Suzano partnership impact, and dividend sustainability in a competitive consumer staples market.
Kimberly-Clark Corporation (KMB) Q2 2025 Analysis: Volume Growth and Strategic Realignment Drive Earnings Recovery
Kimberly-Clark's Q2 2025 volume-led growth and strategic realignment fuel earnings turnaround amid margin pressures and competitive dynamics.
Kimberly‑Clark (KMB): Volume Rebound, High Payouts and a Tight Balance Sheet
Kimberly‑Clark posted its best quarterly volume growth in five years (+~5%), while maintaining a ~3.8% yield and a high payout; cash flow backs the dividend but leverage and currency remain key risks.
Kimberly‑Clark (KMB): Margin Recovery, Cash Flow & Strategic Pivot
After a string of EPS beats and a raised 2025 outlook, Kimberly‑Clark reports improved margins, strong free cash flow conversion and a leverage profile hinging on divestiture proceeds.
Kimberly‑Clark (KMB): Suzano JV, Margin Gains and Dividend Health
Suzano JV delivers **$1.734B** proceeds and a +$0.30–$0.40 EPS tailwind; Powering Care is widening margins while KMB preserves a near-4% yield and heavy payout.